Japan Lifeline Co., Ltd. (7575.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Keisuke Suzuki | President, CEO & Representative Director | -- | -- | 1953 |
| Mr. Takeyoshi Egawa | CFO, Chief Risk Management Officer, Head of Corporate Management Group & Director | -- | -- | 1976 |
| Mr. Atsuhiro Suzuki | VP, COO & Representative Director | -- | -- | 1958 |
| Mr. Kenji Yamada | CCO, Chief Information Security Officer, Head of Corporate Admin Group & Director | -- | -- | 1971 |
| Mr. Toru Takamiya | Executive Officer, Head of R&D and Production Group & Director | -- | -- | 1964 |
| Mr. Tadashi Idei | Senior Operating Officer, Head of Regulatory Affairs Group & Director | -- | -- | 1965 |
| Ms. Yumiko Hoshiba | Chief Risk Management Officer, CISO, Senior Manager of Operations Depa Corporate Man Group& Director | -- | -- | 1962 |
| Mr. Tatsuya Murase | Chief Commercial Officer, Head of Business Operations Headquarters & Director | -- | -- | 1973 |
| Naohiro Nakada | Senior Operating Officer & GM of EP Division Arrhythmia Business Operations Group | -- | -- | -- |
| Mr. Takashi Ito | Senior Operating Officer Head of Arrhythmia Business Operations Group & Board Director | -- | -- | 1968 |
Japan Lifeline Co., Ltd.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 1,216
Description
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters. In addition, the company offers gastrointestinal intervention products that cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and neurovascular intervention products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
Corporate Governance
Upcoming Events
May 7, 2025 at 6:10 AM UTC
Japan Lifeline Co., Ltd. Earnings Date
Recent Events
March 28, 2025 at 12:00 AM UTC
Ex-Dividend Date